Amifostin long-term application vs. supportive care - A multicentric phase III trial in patients with low-risk MDS (IPSS < 1.5).

2000 | conference abstract. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Amifostin long-term application vs. supportive care - A multicentric phase III trial in patients with low-risk MDS (IPSS < 1.5).​
Haase, D.; Schanz, J.; Gassmann, W.; Yilmaz, A.; Vehmeyer, K.; Ludwig, W. D. & Wuchter, C. et al.​ (2000)
Blood96(11) 
Washington​: Amer Soc Hematology.

Documents & Media

License

GRO License GRO License

Details

Authors
Haase, Detlef; Schanz, J.; Gassmann, W.; Yilmaz, A.; Vehmeyer, K.; Ludwig, W. D.; Wuchter, C.; Soeling, Ulrike; Pies, A.; Schulz, T.; Verbeek, W.; Bartels, H.; Binder, Claudia; Griesinger, Frank; Cliche, K. O.; Woermann, Bernhard
Issue Date
2000
Status
published
Publisher
Amer Soc Hematology
Journal
Blood 
ISSN
0006-4971
Extent
261B

Reference

Citations